Abstract
Syzygium samarangense is a plant that is rich in flavonoid compounds. Previous researchrevealed that the dichloromethane fraction from the stem bark extract contained fourbioactive compounds, namely, pinocembrin, uvangoletin, stercurensin, and aurentiacin,which had good antioxidant activity. However, research on the potential of these fourcompounds as an anti-inflammatory has not been revealed. This study aims to continueprevious research in revealing the potential of compounds in the dichloromethane fractionof S. samarangense extract as an anti-inflammatory agent in silico COX-2 inhibitors. Thisstudy uses in silico biocomputation, including drug-likeness analysis and molecular dockinganalysis using COX-2 protein and the control drug rofecoxib. The results showed that thereare compounds that have the potential as anti-inflammatory compounds, namelypinocembrin. However, further studies, such as in vitro and in vivo, are still needed to revealits potential as an anti-inflammatory agent
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
